MMP3 rs679620: Understanding the Stromelysin-1 Variant
The rs679620 variant is a genetic change located within the MMP3 gene, which provides instructions for making the enzyme stromelysin-1. This variant has been studied for its potential role in how the body remodels connective tissues and its association with various musculoskeletal traits.
What each genotype means
Altered matrix turnover profile
You carry two copies of the C allele (frequently reported in complementary orientation as the G allele or Lys45 variant). Published studies have observed statistical associations between this genotype, extracellular matrix remodeling traits such as facial elastosis or wrinkling, and tendon soft-tissue dynamics, though evidence remains limited and underlying functional effects are debated. This profile does not indicate a medical condition or predict specific skin or tendon changes.
Carried by approximately 20% to 25% of individuals in European and South Asian populations, but seen in fewer than 5% of individuals of East Asian ancestry.
Intermediate matrix turnover profile
You carry one copy of the C allele and one copy of the T allele. Research suggests an intermediate likelihood of extracellular matrix characteristics such as solar elastosis and soft-tissue remodelability, though findings across diverse cohorts are mixed and of limited strength. Because this variant is a common natural variation with modest effect sizes, it represents general population variation rather than a health risk.
Carried by approximately 45% to 50% of individuals of European and South Asian ancestry, and around 20% to 30% of individuals of East Asian descent.
Typical matrix turnover profile
You carry two copies of the standard T allele (often noted as the A allele or Glu45 variant in published literature). In association studies, this baseline genotype is generally linked with typical extracellular matrix maintenance and baseline rates of solar skin elastosis and tendon injury risks. Published evidence is limited and non-diagnostic, representing normal physiological variation across populations.
Present in roughly 25% to 30% of European and South Asian populations, and accounts for over 65% to 75% of genotypes in East Asian ancestries.
What is the rs679620 Variant?
The rs679620 variant is a single nucleotide polymorphism (SNP) located within the MMP3 gene on chromosome 11. In genetics, a SNP represents a variation at a single position in the DNA sequence. For rs679620, the two possible nucleotides found at this position are thymine (T) and cytosine (C). This specific location is of interest to researchers because it sits within a gene responsible for producing a critical enzyme involved in maintaining the structural integrity of the body's tissues. While many SNPs have no observable effect on health, researchers investigate variants like rs679620 to determine if they influence how genes are expressed or how proteins function. Because this variant is located in a region that may influence gene regulation, it has been the subject of numerous association studies looking for links between genetic makeup and physical traits or susceptibility to certain conditions.
The Role of the MMP3 Gene
The MMP3 gene encodes a protein called matrix metalloproteinase-3, also known as stromelysin-1. This enzyme belongs to a family of proteins that play a vital role in the breakdown and remodeling of the extracellular matrix, which is the structural framework that supports cells in tissues like skin, tendons, and cartilage. Stromelysin-1 is particularly important because it can activate other enzymes that further degrade matrix components, effectively acting as a key regulator in tissue turnover. By breaking down proteins such as collagen and proteoglycans, MMP3 helps the body maintain a balance between tissue repair and degradation. When this process is disrupted, it can potentially affect the elasticity and strength of connective tissues. Understanding how variations in the MMP3 gene might alter the production or activity of this enzyme is a major focus for scientists studying musculoskeletal health and skin aging.
Research Associations and Evidence
Research into rs679620 has primarily focused on its association with musculoskeletal health, particularly regarding soft tissue injuries. Several studies have explored whether this variant influences the risk of conditions such as Achilles tendinopathy and anterior cruciate ligament (ACL) ruptures. The evidence for these associations is considered limited and sometimes mixed, meaning that while some studies suggest a statistical link, others have not consistently replicated these findings across different populations. Additionally, some research has investigated the role of MMP3 variants in blood pressure regulation and serum protein levels. It is important to note that these associations are statistical in nature, meaning they describe patterns observed in large groups of people rather than predicting individual outcomes. Because the evidence is not definitive, this variant is not currently used as a diagnostic tool for any medical condition.
Population Frequency
The frequency of the rs679620 variant varies significantly across different ancestral groups. Data from large-scale genomic projects like gnomAD indicate that the C allele is quite common globally. In European populations, the T and C alleles are found at relatively similar frequencies, often near 50%. In contrast, populations with East Asian or South Asian ancestry tend to show a higher frequency of the C allele compared to the T allele. These differences in allele frequency are common in human genetics and reflect the diverse evolutionary histories of different populations. Understanding these frequency distributions is essential for researchers when they design studies to ensure that findings are representative and to account for potential population-specific genetic backgrounds.
Interpreting Your Genetic Information
If you have received information about your rs679620 genotype, it is important to view it within the context of current scientific understanding. Genetic associations with complex traits like tendon health are rarely determined by a single variant; they are usually the result of a combination of many genetic factors, environmental influences, and lifestyle choices. Because the evidence linking rs679620 to specific health outcomes is limited and not clinically validated, this information should not be used to make medical decisions or to predict your personal risk for injury. You cannot change your genotype, but you can focus on general health practices, such as maintaining a balanced diet and engaging in appropriate physical activity, which are known to support musculoskeletal health. If you have concerns about your physical health or injury risk, the best course of action is to consult with a healthcare professional or a physical therapist who can provide personalized guidance based on your medical history.
How common is this variant?
The C allele is common globally, with frequencies ranging from approximately 0.49 in European populations to over 0.65 in African and East Asian populations.
Frequently asked questions
Is rs679620 a diagnostic test for injury risk?
No, rs679620 is not a diagnostic test. While some research has explored its association with soft tissue injuries, the evidence is limited and not strong enough to predict an individual's risk.
Can I change my MMP3 genotype?
No, your genotype is determined at conception and cannot be changed. Genetic information provides a snapshot of your inherited DNA sequence.
Does this variant affect skin health?
Some research has investigated the role of MMP3 in extracellular matrix turnover, which is relevant to skin structure. However, there is no clinical evidence that this specific variant can be used to predict skin aging or health.
Should I be worried if I have the C allele?
No, there is no reason to be concerned. The C allele is very common in the general population, and having it does not imply any specific health condition or medical risk.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs679620?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MMP3
The 5A/6A promoter polymorphism modulates MMP3 expression; the 5A allele has been investigated for associations with tendon pathology, though results across different athletic populations are inconsistent.
Matrix metalloproteinase-3 gene polymorphism associated with Achilles tendon pathologies and soft tissue injury susceptibility during athletic training.